Research Analysts' Weekly Ratings Updates for Teva Pharmaceutical Industries

Research Analysts' Weekly Ratings Updates for Teva Pharmaceutical Industries


Several brokerages have updated their recommendations and price targets on shares of Teva Pharmaceutical Industries in the last few weeks: 2/28/2017 - Teva Pharmaceutical Industries was downgraded by analysts at Argus from a "buy" rating to a "hold" rating. They now have a $31.90 price target on the stock, down previously from $59.35.



from Biotech News